Sirt1 and perhaps other longevity-promoting agents (Fig. 1). How these results fit into these well-defined pathways becomes fertile ground for further inquiry. For instance, whether eNOS lies ...
Increased levels of NAD + activate SIRT1, which, in turn, modulates several other molecular signaling pathways, ultimately ...
In an e-mailed response, GSK's Rawcliffe states that the company knew SIRT1 modulation in vitro ... might yield health benefits through other pathways. Thomas Hughes, president and CEO of ...